Inocras

Inocras is a biotech company in San Diego, United States, founded in 2020. It has raised $60.0M across 4 rounds, most recently a $31.0M Series B in August 2026.

Whole genome power. Whole patient impact.

Headquarters
San Diego
Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$60.0M
Last Round
$31.0M Series BAug 2026
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 10 investors for this company. The full record is or through the API.

About

Inocras is a bioinformatics company founded in 2020 by physician-scientists, geneticists, and bioinformaticians to unlock the clinical potential of whole genome sequencing. Operating from San Diego with a CLIA-certified and CAP-accredited laboratory, Inocras has built a proprietary whole genome insight platform that analyzes a patient's complete DNA and delivers curated, clinically actionable findings for oncology and rare disease. The platform serves patients, providers, and researchers: patients receive easy-to-understand reports with genetic counseling support and clinical trial matching; providers gain automated bioinformatics analysis with expert advisory access; and researchers access end-to-end sequencing and interpretation services. Inocras raised $31 million in Series B-3 funding in 2026 to expand its platform into the U.S. market.

Summary

It lists 51–200 employees. It has raised $60.0M in total across 4 rounds, most recently a $31.0M Series B round in Aug 2026. Investors include DSC Investment, IMM Investment and Korea Investment & Securities.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries B-3Aug 2026
$31.0M

Sign up to see all 4 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Inocras on Indexed.vc
<a href="https://indexed.vc/companies/inocras"><img src="https://indexed.vc/api/badge/company/inocras" alt="Inocras on Indexed.vc" width="260" height="76" /></a>